ClinicalTrials.Veeva

Menu

Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test

L

Laser Surgery Care

Status

Completed

Conditions

Anal Dysplasia Diagnosis
Anal Cancer
Anal Canal HPV Infection Diagnosis

Treatments

Device: HC2 collection kit with a swab or brush

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT01104181
R09-HPV-001

Details and patient eligibility

About

This is a study to determine if HC2 HPV testing in the anal canal can detect high-risk HPV and whether this aids in identifying individuals are risk for anal cancer or precancerous lesions.

Enrollment

300 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. male or female 18 years of age or older
  2. screened for anal dysplasia, including MSM and women -

Exclusion criteria

  1. subject has had a previous treatment for anal cancer.
  2. subjects that have used enemas or other foreign substances, in the anal canal or anal sex within 24 hours of collection.
  3. subjects that have bleeding disorders or use anticoagulation treatments. -

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

300 participants in 1 patient group

swab and brush or swab and swab
Experimental group
Description:
we will determine which collection method is superior
Treatment:
Device: HC2 collection kit with a swab or brush

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems